Qing Li

Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Fei Ma, Qiao Li, Shanshan Chen et al. · Journal of Clinical Oncology · 2017 · 228 citations

Metastatic Breast Cancer, Oncology, Biomarker Analysis +12

Evidence That Breast Tissue Stiffness Is Associated with Risk of Breast Cancer

Norman F. Boyd, Qing Li, Olga Melnichouk et al. · PLoS ONE · 2014 · 148 citations · Full text

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

Xiuwen Guan, Fei Ma, Chunxiao Li et al. · Cancer Communications · 2019 · 113 citations · Full text

Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B Infection

Wei Zheng, Qing Li, Xuebin Zou et al. · Radiology · 2019 · 108 citations · Full text

Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin

Qing Li, Ying Yu, Joyce Bischoff et al. · The Journal of Pathology · 2003 · 102 citations